Aldesleukin Completed Phase 1 Trials for Ovarian Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00019136Gene Therapy and Biological Therapy in Treating Patients With Ovarian Epithelial Cancer